NEUROSTECH designs and develops innovative medical devices advancing toward clinical trials, revolutionizing the delivery of therapeutics to the central nervous system (CNS) for neurological disease treatment.

A MedTech company pioneering bioengineered precision intrathecal treatments

We harness cerebrospinal fluid (CSF) dynamics to design cutting‑edge medical devices that deliver intrathecal targeted therapies with unparalleled precision.

Our devices enable clearance of toxic CNS molecules, enhance the delivery of therapeutics to the CNS, and optimize CSF filtration treatments.


NEUROSTECH
mission is to improve the quality of life for patients with neurodegenerative diseases and their families.

  • Our team comprises scientists and biotech/medtech experts with extensive experience in leading biotech companies and research innovation centers.
  • We are deeply focused on neurodegenerative disorders, which impact millions globally and currently lack curative treatments.
Engineering the future of neurology

Pipeline

Our proprietary technology enables the development of a robust pipeline of Medical Devices advancing towards clinical trials:

  • Fully implantable pumpless intrathecal devices enable two key CNS delivery modalities.

  • Stand-alone and extracorporeal smart catheters for CSF filtration.

How do we fight neurodegeneration

INVERLEASE device

A fully implantable solution designed for pseudo-delivery of immunotherapies to treat neurodegenerative diseases.

Why choose our CSF filtration system

Extracorporeal Catheter

Optimized catheters for extracorporeal CSF filtration (liquourpheresis) and lumbar drainage in acute, life-threatening conditions.

What make us unique

Technology

NEUROSTECH is a global leader in harnessing the natural flow of CSF, enabling us to pioneer the development of groundbreaking medical devices.

Our innovations include:

  • Pumpless intrathecal catheters built for efficiency.
  • Advanced subcutaneous reservoirs for optimal patient use.
  • Nanoporous membranes for targeted molecular permeability.

Learn how we’re leading the way in medical device innovation…

Worlwide community of collaborators

Collaborations

NEUROSTECH successfully engages in both Spanish and international projects to dive the development of new technology and products.

Excellent research, positive results

Publications

Selected outcomes of our internal and collaborative efforts are regularly published in high-impact journals.

Meet us at…

ASTURIAS
Investors Day

  • April 24, 2025

  • Laboral Centro de Arte
    Gijón, Spain

6th Annual CNS
Drug Delivery Summit

  • December 3–5, 2024

  • The Westin Boston Seaport District
    Boston, MA, USA

MEDICA Healthcare
Brokerage Event

  • November 11–14, 2024

  • Düsseldorf Messe
    Düsseldorf, Germany